Abstract
The invention relates to a method of cardiac imaging using hyperpolarised 13C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.
Original language | English |
---|---|
IPC | A61B 5/ 055 A I |
Patent number | US2009162287 |
Filing date | 25/06/2009 |
Country/Territory | United States |
Priority date | 18/11/2005 |
Priority number | WO2005NO00434 |
Publication status | Published - 25 Jun 2009 |
Externally published | Yes |